Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand.
Res Pract Thromb Haemost. 2023 Aug 9;7(6):102163. doi: 10.1016/j.rpth.2023.102163. eCollection 2023 Aug.
Res Pract Thromb Haemost. 2023.
PMID: 37720484
Free PMC article.
Real-world evidence on efmoroctocog alfa in patients with haemophilia A: A systematic literature review of treatment experience in Europe.
Blatný J, Nielsen EM, Reitzel SB, McMillan AC, Danø A, Bystrická L, Kragh N, Klamroth R.
Blatný J, et al. Among authors: bystricka l.
Haemophilia. 2023 Jul;29(4):963-974. doi: 10.1111/hae.14797. Epub 2023 May 27.
Haemophilia. 2023.
PMID: 37243934
Review.
Item in Clipboard
Cost-effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.
Kragh N, Tytula A, Pochopien M, Aballéa S, Toumi M, Hakimi Z, Nazir J, Bystrická L, Fatoye F.
Kragh N, et al. Among authors: bystricka l.
Eur J Haematol. 2023 Mar;110(3):262-270. doi: 10.1111/ejh.13901. Epub 2022 Dec 11.
Eur J Haematol. 2023.
PMID: 36398467
Free PMC article.
Item in Clipboard
Comment on "Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies".
Horneff R, Bystrická L, Santagostino E, Lethagen S, Casiano S.
Horneff R, et al. Among authors: bystricka l.
Semin Thromb Hemost. 2022 Mar;48(2):251-252. doi: 10.1055/s-0041-1736573. Epub 2021 Nov 8.
Semin Thromb Hemost. 2022.
PMID: 34749400
No abstract available.
Item in Clipboard
Cite
Cite